isct: Available PET Tracers

[¹⁸F]FDG

Marketing license
Visualization of glucose metabolism, e.g., tumors

[¹⁸F]FPyGal

Manufacturing Authorization
Marker of senescence, tumors

[¹⁸F]PSMA-1007

Manufacturing Authorization
Marker of PSMA, prostate cancer

[¹⁸F]Fluoroethyltyrosine (FET)

under AMG §13 2b
Marker of amino acid transport, brain tumors

[¹⁸F]Fluoroethylcholine (FEC)

under AMG §13 2b
Marker of proliferation, prostate cancer, parathyroid gland

[¹⁸F]Fluoride

under AMG §13 2b
Marker of bone uptake, bone metastases

[¹⁸F]SiFalin-TATE

under AMG §13 2b
Marker of somatostatin receptors, neuroendocrine tumors

[¹¹C]PIB

Manufacturing Authorization
Marker of beta-amyloid plaques, Alzheimers disease

[¹¹C]Raclopride

Manufacturing Authorization
Marker of dopamine-D2-receptor, neurology, psychiatry

[¹¹C]Methionine

Manufacturing Authorization
Marker of amino acid utilization, brain tumors

[⁶⁴Cu]Cu-NODAGA-hJF5-AK

under AMG §13 2b
Marker of aspergillus infection

[⁶⁴Cu]Cu-NOTA-GD2-AK

under AMG §13 2b
Marker of GD2 antigen, neuroblastoma

[⁶⁴Cu]Cu-NOTA-GPVI

under AMG §13 2b
Marker of atherosclerotic plaques, cardiology

[⁶⁴Cu]Cu-DOTA-CD19-AK

under AMG §13 2b
Marker of CD19 antigen, tumors

[⁸⁹Zr]Zr-Df-IAB22M2C

Manufacturing Authorization
Marker of CD8 antigen, tumors

in clinical trials. First production site of a CD8 tracer in Europe, production for EU and UK